Hydrochloric Acid

Hydrochloric Acid

SCHEMBL378928

Cl.[Na+].[Na+].[Na+].[O-]B([O-])[O-]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL722272 1.00
SCHEMBL1147998 0.91
SCHEMBL11599908 0.91
SCHEMBL8971063 0.91
SCHEMBL3846 0.91
SCHEMBL15875 0.91
SCHEMBL1568303 0.91
SCHEMBL10589186 0.91
SCHEMBL25308070 0.83
Water SCHEMBL3379708 0.83 CA1 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100143965-A1 METHOD FOR PRODUCTION OF ANTIMUTAGENIC SUBSTANCE USING LACTIC ACID BACTERIUM KIGEN BIOGENICS INSTITUTE CO., LTD. (JP) 2010-06-10 US claimed
US-20100063318-A1 Purification Method of Crude Naphthalene Dicarboxylic Acid Using Microorganism and 2,6-Naphthalene Dicarboxylic Acid in Crystalline Form Obtained by Using the Same KIM DONG SUNG 2010-03-11 US claimed
EP-1960341-A1 PURIFICATION METHOD OF CRUDE NAPHTHALENE DICARBOXYLIC ACID USING MICROORGANISM AND 2,6-NAPHTHALENE DICARBOXYLIC ACID IN CRYSTALLINE FORM OBTAINED BY USING THE SAME Hyosung Corporation (KR) 2008-08-27 EP claimed
WO-2008013347-A1 PURIFICATION METHOD OF CRUDE NAPHTHALENE DICARBOXYLIC ACID USING BENZALDEHYDE DEHYDROGENASE FROM RECOMBINATED MICROORGANISM AND 2,6-NAPHTHALENE DICARBOXYLIC ACID IN CRYSTALLINE FORM OBTAINED BY USING THE SAME HYOSUNG CORPORATION (KR) 2008-01-31 WO claimed
WO-2008004731-A1 PURIFICATION METHOD OF CRUDE NAPHTHALENE DICARBOXYLIC ACID USING RECOMBINATED MICROORGANISM AND 2,6-NAPHTHALENE DICARBOXYLIC ACID IN CRYSTALLINE FORM OBTAINED BY USING THE SAME HYOSUNG CORPORATION (KR) 2008-01-10 WO claimed
WO-2007069805-A1 PURIFICATION METHOD OF CRUDE NAPHTHALENE DICARBOXYLIC ACID USING MICROORGANISM AND 2,6-NAPHTHALENE DICARBOXYLIC ACID IN CRYSTALLINE FORM OBTAINED BY USING THE SAME HYOSUNG CORPORATION (KR) 2007-06-21 WO claimed
EP-0750678-B1 NOVEL METHOD FOR THE CONDITIONING OF LIQUID SAMPLES FOSS ELECTRIC AS (DK) 1999-09-08 EP claimed
EP-0750678-A1 NOVEL METHOD FOR THE CONDITIONING OF LIQUID SAMPLES Foss Electric A/S (DK) 1997-01-02 EP claimed
WO-1995025174-A1 NOVEL METHOD FOR THE CONDITIONING OF LIQUID SAMPLES FOSS ELECTRIC A/S (DK) 1995-09-21 WO claimed
JP-1222783-A None JP disclosed
CN-111808173-B Polypeptide-quantum dot compound, preparation method and application thereof 国家纳米科学中心 2024-02-23 CN disclosed
CN-112379100-B Distribution detection method for immune-epidemic area of platelet anti-human globulin experiment 中国科学院苏州生物医学工程技术研究所 2024-01-23 CN disclosed
US-10627412-B2 Periodontal-disease-specific peptide, and treatment and diagnosis of periodontal disease using same KAGOSHIMA UNIVERSITY (JP) 2020-04-21 US disclosed
EP-2548888-B1 PERIODONTAL-DISEASE-SPECIFIC PEPTIDE, AND TREATMENT AND DIAGNOSIS OF PERIODONTAL DISEASE USING SAME UNIV KAGOSHIMA (JP) 2017-11-01 EP disclosed
EP-0974579-A1 Novel nitroisourea derivatives Mitsui Chemicals, Inc. (JP) 2000-01-26 EP disclosed
EP-0750678-B1 NOVEL METHOD FOR THE CONDITIONING OF LIQUID SAMPLES FOSS ELECTRIC AS (DK) 1999-09-08 EP disclosed
US-5798221-A Method for the conditioning of liquid samples FOSS ELECTRIC A/S (DK) 1998-08-25 US disclosed
EP-0750678-A1 NOVEL METHOD FOR THE CONDITIONING OF LIQUID SAMPLES Foss Electric A/S (DK) 1997-01-02 EP disclosed
WO-1995025174-A1 NOVEL METHOD FOR THE CONDITIONING OF LIQUID SAMPLES FOSS ELECTRIC A/S (DK) 1995-09-21 WO disclosed
JP-H01222783-A PRODUCTION OF IMMOBILIZED BIOLOGICAL CATALYST JAPAN VILENE CO LTD 1989-09-06 JP disclosed